Approved regimen
Approved labeled regimen
Product-, indication-, and jurisdiction-specific — see the monograph
- Copaxone label (FDA). The label summary below is product-, indication-, and jurisdiction-specific; consult the full current label and a licensed clinician/pharmacist.
- 20 mg/mL: administer once daily subcutaneously via single-dose prefilled syringe.
- 40 mg/mL: administer three times per week (at least 48 hours apart) subcutaneously via single-dose prefilled syringe.
- Both strengths are supplied as ready-to-use single-dose prefilled syringes; the lyophilized formulation was discontinued.
- Only for subcutaneous use; not for intravenous or intramuscular administration.